NCT05096364 A Phase 2 Study of Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis Status COMPLETED Phase PHASE2
NCT05084417 A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions Status ENROLLING_BY_INVITATION Phase N/A
NCT05076812 Interleukin 38 as a Biomarker for Metabolic Syndrome in Psoriatic Patients Status UNKNOWN Phase N/A
NCT05065762 Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment Status COMPLETED Phase N/A
NCT05064748 Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in Adults Status UNKNOWN Phase PHASE4
NCT05056168 Validation of a Dermatology-Specific Treatment Satisfaction Instrument Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05051943 A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response Status COMPLETED Phase N/A
NCT05044234 A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis Status TERMINATED Phase PHASE2
NCT05003531 A Study to Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT04971239 Topical Methotrexate Microemulsion in the Treatment of Plaque Psoriasis Status UNKNOWN Phase PHASE4
NCT04967508 A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT04950218 Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis Status RECRUITING Phase N/A
NCT04930042 Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT04927195 Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma Status COMPLETED Phase PHASE1
NCT04914429 A Study of Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT04912401 the Efficacy and Safety of Etanercept (Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis Status RECRUITING Phase N/A